Here are relevant reports on : pulmonary-hypertension-market
-
Pulmonary Arterial Hypertension Market by Drug Class (SGC Stimulators, Endothelin Receptor Antagonists, Type (Innovative, Generics) – Global Forecast to 2027
The global pulmonary arterial hypertension market is projected to reach USD 9 billion by 2027 from USD 7 billion in 2022, at a CAGR of 5% during the forecast period
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Hypertension Management Devices Market - Global Trends, Opportunities and Forecasts to 2017 - [Renal Denervation, Carotid Artery Stimulation, Respiratory Modulation]
Treatment of hypertension is experiencing change as traditional drug based approach is giving way to treatment with devices which acts on Renal Sympathetic denervation as well as Carotid Sinus Stimulation and novel devices such as respiratory modulation devices.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Physiotherapy Equipment Market by Product (Equipment, Accessories), Application (Musculoskeletal, Neurological, Cardiovascular & Pulmonary, Pediatric & Gynecological Application), End User, Region - Global Forecast to 2029
The global physiotherapy equipment market, valued at US$6.26 billion in 2023, stood at US$6.70 billion in 2024 and is projected to advance at a resilient CAGR of 7.1 % from 2024 to 2029, culminating in a forecasted valuation of US$9.45 billion by the end of the period. The growth in this market is driven by an increasing aging population, rising rates of chronic diseases, a higher incidence of sports injuries, technological advancements, expanding healthcare and insurance coverage supported by government initiatives, and the increased global adoption of physiotherapy equipment.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Digital Stethoscopes Market by Design Type (Tube-based, Tubeless), Connectivity (Wireless, Wired), Application (Cardiology, Pulmonary), End User (Hospitals, Urgent Care Centers, Ambulatory Care Centers, Home Care), and Region - Global Forecast to 2032
The global digital stethoscopes market, valued at US$467.7 million in 2024, stood at US$491.7 million in 2025 and is projected to advance at a resilient CAGR of 5.5% from 2025 to 2032, culminating in a forecasted valuation of US$717.3 million by the end of the period. The rising prevalence of chronic diseases, such as cardiovascular and respiratory conditions, combined with the introduction and approval of advanced digital stethoscopes, is driving significant market growth.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures – Global Forecasts to 2018
The global pediatric interventional cardiology market is segmented on the basis of type of devices and geography. Based on the type of device, the market is further segmented into congenital heart defect closure devices, transcatheter heart valves, and others (catheters, guidewires, balloons, and stents). Based on geography, this market is divided into four geographic regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). This report also includes the number of pediatric interventional cardiology procedures performed across different regions.
- Published: March 2014
- Price: $ 4950
- TOC Available:
-
Pulmonary/ Respiratory Drug Delivery Market by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications (COPD) - Global Forecast to 2021
The global pulmonary drug delivery market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this market is mainly driven by increasing preference of pulmonary route as an alternate route of drug delivery, rising focus on the development of smart/digital inhalers and increasing incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis. Emerging markets such as India, China, & Japan and growth in online marketing channels are expected to offer lucrative growth opportunities for market players in the coming years. On the other hand, factors such as regulatory issues and pricing pressures are the major factors restraining market growth.
- Published: February 2017
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029
The global pharmaceutical drug delivery market, valued at US$1,831.1 million in 2023, stood at US$1,949.4 million in 2024 and is projected to advance at a resilient CAGR of 5.5% from 2024 to 2029, culminating in a forecasted valuation of US$2,546.0 million by the end of the period. The increasing patient population with chronic diseases, coupled with the growing geriatric population, rising technological advancements in pharmaceutical drug delivery products offering enhanced patient convenience and compliance, the growing adoption of home-based and self-administration, rising government initiatives promoting accessibility to pharmaceutical drug delivery, and the increasing demand for biosimilars and biologics are likely to support market growth.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Carrier Screening Market by Product and Service, Type (Expanded (Customized, Predesigned) Targeted Diseases, Medical condition (Hematologic, Pulmonary), Technology (DNA Sequencing, PCR), End User, Region - Global Forecast to 2028
The global carrier screening market, valued at US$1.8 billion in 2022, stood at US$2.2 billion in 2023 and is projected to advance at a resilient CAGR of 19.7% from 2023 to 2028, culminating in a forecasted valuation of US$5.4 billion by the end of the period. The expansion of this market is majorly due to the development and availability of expanded carrier screening panels that cover a wide range of genetic conditions contribute to the market's growth.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Renal Denervation Systems Market by Technology (Ultrasound. RF, Microinfusion), Product (Single Electrode Catheter, Neurve Modifying Agents), Application (Heart Failure, Hypertension, Diabetes), End User (Hospitals, Ambulatory Care) - Forecasts to 2022
The global renal denervation systems market is poised to witness a steady growth during the forecast period. This is expected to be driven by major factors such as rising prevalence of hypertension, increasing geriatric population, clinical advantages such as fast recovery time with minimal complications, technological advancements to develop alternative technologies. Moreover, increasing clinical trials to validate clinical efficacy of renal denervation and cost effectiveness of the procedure over conventional surgeries are expected to offer high growth opportunities for players active in the global renal denervation systems market.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Oxygen Concentrators Market by Type (Portable, Stationary), Technology (Continuous and Pulse Flow), Flowrate (0-5L/Min, 5-10L/Min, Above 10L/Min), Application (Chronic Obstructive Pulmonary Disorder), End User (Home Care Settings) - Global Forecast to 2030
The global oxygen concentrators market, valued at US$1.20 billion in 2024, stood at US$1.27 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$1.71 billion by the end of the period. Air pollution and smoking drive up demand for oxygen concentrators due to their role in worsening respiratory diseases like COPD and asthma, especially in urban and industrial areas.
- Published: August 2025
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
